prednisolone has been researched along with Endothelioma, Vascular in 26 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is currently no consensus on the second-line management of Kaposiform hemangioendothelioma (KHE) that was resistant to prednisolone and vincristine." | 7.81 | Successful treatment of Kaposiform hemangioendothelioma with everolimus. ( Ito, S; Miyazaki, O; Mori, T; Nakazawa, A; Terashima, K; Uno, T, 2015) |
| "Sirolimus was added; he became transfusion independent with no further bleeding and reduction in tumor size." | 5.48 | Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. ( Cashell, J; Helm, K; Smink, GM; Xavier, F, 2018) |
| "Sirolimus was effective and safe for the treatment of progressive KHE." | 5.46 | Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study. ( Chen, S; Ji, Y; Li, K; Li, Y; Liu, X; Lu, G; Tang, X; Wang, C; Wang, Q; Wu, H; Xia, C; Xiang, B; Xu, T; Xu, Z; Yang, G; Yang, K; Yao, W, 2017) |
| "Sirolimus is an effective therapy for children with kaposiform hemangioendothelioma with or without the Kasabach-Merritt phenomenon." | 3.88 | ( Dillingham, CS; Givner, LB; McLean, TW; Rinker, EK; Russell, TB, 2018) |
| "There is currently no consensus on the second-line management of Kaposiform hemangioendothelioma (KHE) that was resistant to prednisolone and vincristine." | 3.81 | Successful treatment of Kaposiform hemangioendothelioma with everolimus. ( Ito, S; Miyazaki, O; Mori, T; Nakazawa, A; Terashima, K; Uno, T, 2015) |
| " A 28-day-old boy with TSH level of 77 mIU/mL on neonatal screening and diagnosed as congenital hypothyroidism was started on L-thyroxine (L-T4) (11 μg/kg/day) therapy on the 21(th) day of life." | 3.76 | Hypothyroidism due to hepatic hemangioendothelioma: a case report. ( Ağladioğlu, SY; Aycan, Z; Baş, VN; Bozkurt, C; Çetinkaya, S; Kendirci, HN; Özdemir, S, 2010) |
| "Sirolimus was added; he became transfusion independent with no further bleeding and reduction in tumor size." | 1.48 | Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. ( Cashell, J; Helm, K; Smink, GM; Xavier, F, 2018) |
| "Sirolimus was effective and safe for the treatment of progressive KHE." | 1.46 | Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study. ( Chen, S; Ji, Y; Li, K; Li, Y; Liu, X; Lu, G; Tang, X; Wang, C; Wang, Q; Wu, H; Xia, C; Xiang, B; Xu, T; Xu, Z; Yang, G; Yang, K; Yao, W, 2017) |
| "Infantile hemangioendothelioma is a rare benign vascular tumor of the liver." | 1.35 | Infantile hepatic hemangioendothelioma: an 8-month old infant successfully treated with a corticosteroid. ( Al-Tonbary, Y; Fouda, A, 2009) |
| "Hepatic hemangioendotheliomas are rare tumors in childhood." | 1.34 | Infantile hepatic hemangioendothelioma: clinical presentation and treatment. ( Ozkan, TB; Sevinir, B, 2007) |
| "Hepatic hemangioendothelioma is rare." | 1.31 | Infantile hepatic hemangioendothelioma presenting as early heart failure: report of two cases. ( Ko, SF; Kuo, HW; Liang, CD; Lu, CC; Tiao, MM, 2002) |
| "Prednisolone was ineffective when application was initiated after arthritis was fully developed, i." | 1.29 | Prednisolone reduces experimental arthritis, and inflammatory tissue destruction in SCID mice infected with Borrelia burgdorferi. ( Böggemeyer, E; Del Pozo, E; Hurtenbach, U; Museteanu, C; Simon, MM; Stehle, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y | 2 |
| Chen, S | 2 |
| Zhou, J | 1 |
| Yang, K | 2 |
| Zhang, X | 1 |
| Xiang, B | 2 |
| Qiu, T | 1 |
| Gong, X | 1 |
| Zhang, Z | 1 |
| Lan, Y | 1 |
| Hu, F | 1 |
| Kong, F | 1 |
| Qiu, Q | 1 |
| Zhang, Y | 1 |
| Li, K | 1 |
| Xu, Z | 1 |
| Yao, W | 1 |
| Lu, G | 1 |
| Liu, X | 1 |
| Xia, C | 1 |
| Wang, Q | 1 |
| Li, Y | 1 |
| Wang, C | 1 |
| Yang, G | 1 |
| Tang, X | 1 |
| Xu, T | 1 |
| Wu, H | 1 |
| Russell, TB | 1 |
| Rinker, EK | 1 |
| Dillingham, CS | 1 |
| Givner, LB | 1 |
| McLean, TW | 1 |
| Cashell, J | 1 |
| Smink, GM | 1 |
| Helm, K | 1 |
| Xavier, F | 1 |
| Emad, A | 1 |
| Fadel, S | 1 |
| El Wakeel, M | 1 |
| Nagy, N | 1 |
| Zamzam, M | 1 |
| Kieran, MW | 1 |
| El Haddad, A | 1 |
| Fichel, F | 1 |
| Eschard, C | 1 |
| Zachar, D | 1 |
| Munzer, M | 1 |
| Bernard, P | 1 |
| Grange, F | 1 |
| Downing, A | 1 |
| Chauhan, A | 1 |
| Lotterman, C | 1 |
| Craver, R | 1 |
| Warrier, R | 1 |
| Uno, T | 1 |
| Ito, S | 1 |
| Nakazawa, A | 2 |
| Miyazaki, O | 1 |
| Mori, T | 1 |
| Terashima, K | 1 |
| Saito, M | 1 |
| Gunji, Y | 1 |
| Kashii, Y | 1 |
| Odaka, J | 1 |
| Yamauchi, T | 1 |
| Kanai, N | 1 |
| Momoi, MY | 1 |
| Al-Tonbary, Y | 1 |
| Fouda, A | 1 |
| Tamai, N | 1 |
| Hashii, Y | 1 |
| Osuga, K | 1 |
| Chihara, T | 1 |
| Morii, E | 1 |
| Aozasa, K | 1 |
| Yoshikawa, H | 1 |
| Çetinkaya, S | 2 |
| Kendirci, HN | 1 |
| Ağladioğlu, SY | 1 |
| Baş, VN | 1 |
| Özdemir, S | 1 |
| Bozkurt, C | 2 |
| Aycan, Z | 1 |
| Incesoy Özdemir, S | 1 |
| Orün, UA | 1 |
| Sahin, G | 1 |
| Yüksek, N | 1 |
| Ertem, U | 1 |
| Kuroda, T | 1 |
| Kumagai, M | 1 |
| Nosaka, S | 1 |
| Takimoto, T | 1 |
| Hoshino, K | 1 |
| Jahnel, J | 1 |
| Lackner, H | 1 |
| Reiterer, F | 1 |
| Urlesberger, B | 1 |
| Urban, C | 1 |
| Lu, CC | 1 |
| Ko, SF | 1 |
| Liang, CD | 1 |
| Kuo, HW | 1 |
| Tiao, MM | 1 |
| Miller, MA | 1 |
| Sandler, AD | 1 |
| Cho, SH | 1 |
| Na, KS | 1 |
| Jothilakshmi, K | 1 |
| Matthai, J | 1 |
| Paul, S | 1 |
| Singal, AK | 1 |
| Sevinir, B | 1 |
| Ozkan, TB | 1 |
| Takato, T | 1 |
| Komuro, Y | 1 |
| Yonehara, Y | 1 |
| Fujikawa, I | 1 |
| Tei, T | 1 |
| Yagasaki, F | 1 |
| Yamamoto, K | 1 |
| Nagata, K | 1 |
| Hamaguchi, H | 1 |
| Miyake, S | 1 |
| Hurtenbach, U | 1 |
| Böggemeyer, E | 1 |
| Stehle, T | 1 |
| Museteanu, C | 1 |
| Del Pozo, E | 1 |
| Simon, MM | 1 |
| Kubo, M | 1 |
| Koga, M | 1 |
| Fujii, T | 1 |
| Kaneko, T | 1 |
| Yamashita, K | 1 |
| Kokubu, T | 1 |
| Bergström, K | 1 |
| Enoksson, P | 1 |
| Gamstorp, I | 1 |
| Naeser, P | 1 |
| Chang, JS | 1 |
| Young, ML | 1 |
| Chuu, WM | 1 |
| Lue, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma: a Randomized Controlled Trial[NCT05324384] | Phase 2 | 30 participants (Anticipated) | Interventional | 2022-04-05 | Recruiting | ||
| Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome[NCT03188068] | Phase 2 | 30 participants (Actual) | Interventional | 2017-06-01 | Completed | ||
| Different Doses of Sirolimus for Kaposiform Hemangioendothelioma: a Randomized Clinical Trial[NCT04775173] | Phase 2 | 79 participants (Actual) | Interventional | 2021-02-17 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone and Endothelioma, Vascular
| Article | Year |
|---|---|
Infantile cardiac hemangioendothelioma.
Topics: Heart Atria; Heart Neoplasms; Hemangioendothelioma; Humans; Infant; Male; Prednisolone | 1992 |
1 trial available for prednisolone and Endothelioma, Vascular
| Article | Year |
|---|---|
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Topics: Hemangioendothelioma; Humans; Infant; Kasabach-Merritt Syndrome; Prednisolone; Sarcoma, Kaposi; Siro | 2022 |
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Topics: Hemangioendothelioma; Humans; Infant; Kasabach-Merritt Syndrome; Prednisolone; Sarcoma, Kaposi; Siro | 2022 |
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Topics: Hemangioendothelioma; Humans; Infant; Kasabach-Merritt Syndrome; Prednisolone; Sarcoma, Kaposi; Siro | 2022 |
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Topics: Hemangioendothelioma; Humans; Infant; Kasabach-Merritt Syndrome; Prednisolone; Sarcoma, Kaposi; Siro | 2022 |
24 other studies available for prednisolone and Endothelioma, Vascular
| Article | Year |
|---|---|
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Therapy, | 2018 |
Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Disorders; Child; Hemangioendothel | 2018 |
Outcome of Children Treated for Infantile Hepatic Hemangioendothelioma.
Topics: Antineoplastic Agents, Hormonal; Combined Modality Therapy; Female; Follow-Up Studies; Hemangioendot | 2020 |
[Kaposiform haemangioendothelioma associated with B-cell acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Combined Modality Therapy | 2013 |
Giant vascular malformation with thrombocytopenia in a newborn.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Arm; Female; Hemangioendothelioma; Huma | 2013 |
Successful treatment of Kaposiform hemangioendothelioma with everolimus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Everolimus; Hemang | 2015 |
Refractory kaposiform hemangioendothelioma that expressed vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3: a case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Benzamidine | 2009 |
Infantile hepatic hemangioendothelioma: an 8-month old infant successfully treated with a corticosteroid.
Topics: Anti-Inflammatory Agents; Female; Hemangioendothelioma; Humans; Infant; Liver Neoplasms; Prednisolon | 2009 |
Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.
Topics: Antineoplastic Agents, Hormonal; Deltoid Muscle; Diagnosis, Differential; Disseminated Intravascular | 2010 |
Hypothyroidism due to hepatic hemangioendothelioma: a case report.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Congenital Hypothyroidism; Hemangioendothelioma; Ho | 2010 |
Successful treatment of pulmonary arteriovenous malformation and infantile hepatic hemangioendothelioma with alpha-interferon.
Topics: Arteriovenous Malformations; Cyanosis; Drug Therapy, Combination; Glucocorticoids; Hemangioendotheli | 2011 |
Critical infantile hepatic hemangioma: results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Blood Coagulation Disorders; Cardiac Output, Hig | 2011 |
Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineopla | 2012 |
Infantile hepatic hemangioendothelioma presenting as early heart failure: report of two cases.
Topics: Female; Heart Failure; Hemangioendothelioma; Hepatic Artery; Humans; Ligation; Liver Neoplasms; Male | 2002 |
Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma.
Topics: Biomarkers, Tumor; Hemangioendothelioma; Hepatectomy; Hip Contracture; Humans; Infant; Liver Neoplas | 2005 |
Haemangioendothelioma on the conjunctiva of the upper eyelid.
Topics: Administration, Oral; Biomarkers, Tumor; Conjunctival Neoplasms; Eyelid Neoplasms; Glucocorticoids; | 2006 |
Symptomatic hepatic hemangioendothelioma in a newborn.
Topics: Disease Progression; Female; Glucocorticoids; Hemangioendothelioma; Humans; Infant, Newborn; Liver N | 2006 |
Infantile hepatic hemangioendothelioma: clinical presentation and treatment.
Topics: Abdomen; Alanine Transaminase; Aspartate Aminotransferases; Dilatation, Pathologic; Female; Glucocor | 2007 |
Giant hemangioma of the parotid gland associated with Kasabach-Merritt syndrome: a case report.
Topics: Hemangioendothelioma; Hemangioma; Humans; Infant; Male; Parotid Neoplasms; Prednisolone; Syndrome; T | 1993 |
[Autopsy case of angiotropic lymphoma complicated with interstitial pneumonia during VEPA therapy and monocytosis in the early stage].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Cyclophosphamide; Doxorubicin; He | 1996 |
Prednisolone reduces experimental arthritis, and inflammatory tissue destruction in SCID mice infected with Borrelia burgdorferi.
Topics: Animals; Arthritis, Infectious; Borrelia burgdorferi Group; Cell Adhesion Molecules; Female; Hemangi | 1996 |
Bilateral adrenal lymphoma with neoplastic angioendotheliosis.
Topics: Acute Kidney Injury; Addison Disease; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy | 1997 |
Haemangio-endothelioma of the orbit.
Topics: Female; Hemangioendothelioma; Humans; Infant, Newborn; Infant, Newborn, Diseases; Orbital Neoplasms; | 1978 |